• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗疟过氧化物抑制人冠状病毒。

Inhibition of Human Coronaviruses by Antimalarial Peroxides.

机构信息

Department of Pediatrics, Division of Infectious Disease, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States.

Coppe Healthcare Solutions, Waukesha, Wisconsin 53186, United States.

出版信息

ACS Infect Dis. 2021 Jul 9;7(7):1985-1995. doi: 10.1021/acsinfecdis.1c00053. Epub 2021 Mar 30.

DOI:10.1021/acsinfecdis.1c00053
PMID:33783182
Abstract

As the toll of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic continues, efforts are ongoing to identify new agents and repurpose safe drugs for its treatment. Antimalarial peroxides have reported antiviral and anticancer activities. Here, we evaluated the activities of artesunate (AS) and two ozonides (OZ418 and OZ277) against human α-coronavirus NL63 and β-coronaviruses OC43 and SARS-CoV-2 in several cell lines. OZ418 had the best selectivity index (SI) in NL63-infected Vero cells and MK2 cells. The overall SI of the tested compounds was cell-type dependent. In OC43-infected human foreskin fibroblasts, AS had the best cell-associated SI, ≥17 μM, while the SI of OZ418 and OZ277 was ≥12 μM and ≥7 μM, respectively. AS did not inhibit SARS-CoV-2 in either Vero or Calu-3 cells. A comparison of OZ418 and OZ277 activity in SARS-CoV2-infected Calu-3 cells revealed similar EC (5.3 μM and 11.6 μM, respectively), higher than the EC of remdesivir (1.0 ± 0.1 μM), but the SI of OZ418 was higher than OZ277. A third ozonide, OZ439, inhibited SARS-CoV-2 efficiently in Vero cells, but compared to OZ418 in Calu-3 cells, it showed higher toxicity. Improved inhibition of SARS-CoV-2 was observed when OZ418 was used together with remdesivir. Although the EC of ozonides might be clinically achieved in plasma after intravenous administration, sustained virus suppression in tissues will require further considerations, including drug combination. Our work supports the potential repurposing of ozonides and calls for future models.

摘要

随着严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)大流行的持续,人们正在努力寻找新的药物,并重新利用安全药物来治疗它。抗疟过氧化物具有抗病毒和抗癌活性。在这里,我们评估了青蒿琥酯(AS)和两种臭氧(OZ418 和 OZ277)对几种细胞系中的人α冠状病毒 NL63 和β冠状病毒 OC43 和 SARS-CoV-2 的活性。OZ418 在 NL63 感染的 Vero 细胞和 MK2 细胞中具有最佳的选择性指数(SI)。测试化合物的总体 SI 依赖于细胞类型。在 OC43 感染的人包皮成纤维细胞中,AS 的细胞相关 SI 最佳,≥17 μM,而 OZ418 和 OZ277 的 SI 分别为≥12 μM 和≥7 μM。AS 既不能抑制 Vero 细胞也不能抑制 Calu-3 细胞中的 SARS-CoV-2。OZ418 和 OZ277 在 SARS-CoV2 感染的 Calu-3 细胞中的活性比较表明,EC 相似(分别为 5.3 μM 和 11.6 μM),高于瑞德西韦(1.0 ± 0.1 μM)的 EC,但 OZ418 的 SI 高于 OZ277。第三种臭氧 OZ439 能有效抑制 Vero 细胞中的 SARS-CoV-2,但与 Calu-3 细胞中的 OZ418 相比,其毒性更高。当 OZ418 与瑞德西韦联合使用时,观察到对 SARS-CoV-2 的抑制作用增强。尽管臭氧在静脉给药后血浆中的 EC 可能在临床上达到,但需要进一步考虑包括药物联合使用在内的持续抑制病毒在组织中的扩散。我们的工作支持臭氧的潜在再利用,并呼吁未来的模型。

相似文献

1
Inhibition of Human Coronaviruses by Antimalarial Peroxides.抗疟过氧化物抑制人冠状病毒。
ACS Infect Dis. 2021 Jul 9;7(7):1985-1995. doi: 10.1021/acsinfecdis.1c00053. Epub 2021 Mar 30.
2
Anti-SARS-CoV-2 Potential of Artemisinins In Vitro.青蒿素体外抗新型冠状病毒 2 的潜力
ACS Infect Dis. 2020 Sep 11;6(9):2524-2531. doi: 10.1021/acsinfecdis.0c00522. Epub 2020 Aug 18.
3
Hepatitis C Virus Protease Inhibitors Show Differential Efficacy and Interactions with Remdesivir for Treatment of SARS-CoV-2 .丙型肝炎病毒蛋白酶抑制剂对 SARS-CoV-2 治疗的疗效和与瑞德西韦的相互作用存在差异。
Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0268020. doi: 10.1128/AAC.02680-20.
4
Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2.比较吉西他滨与 2'-氟-2'-脱氧胞苷的抗病毒活性及联合瑞德西韦治疗 SARS-CoV-2。
Int J Mol Sci. 2021 Feb 4;22(4):1581. doi: 10.3390/ijms22041581.
5
Antimalarial drugs inhibit the replication of SARS-CoV-2: An in vitro evaluation.抗疟药物抑制 SARS-CoV-2 的复制:体外评价。
Travel Med Infect Dis. 2020 Sep-Oct;37:101873. doi: 10.1016/j.tmaid.2020.101873. Epub 2020 Sep 8.
6
Inhibition of Cytomegalovirus Replication with Extended-Half-Life Synthetic Ozonides.用长半衰期合成臭氧化物抑制巨细胞病毒复制。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01735-18. Print 2019 Jan.
7
Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues.一系列抗疟疾喹啉类似物的广谱抗冠状病毒活性。
Antiviral Res. 2021 Sep;193:105127. doi: 10.1016/j.antiviral.2021.105127. Epub 2021 Jul 1.
8
Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro.阿昔莫司钠对 SARS-CoV-2 的体外抗病毒和病毒杀灭活性。
Antiviral Res. 2021 Jul;191:105089. doi: 10.1016/j.antiviral.2021.105089. Epub 2021 May 16.
9
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19.抗 HCV 药物达卡他韦和索非布韦对 COVID-19 病因 SARS-CoV-2 的体外抗病毒活性。
J Antimicrob Chemother. 2021 Jun 18;76(7):1874-1885. doi: 10.1093/jac/dkab072.
10
AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 and a Promising Oral Antiviral for Treatment of COVID-19.AT-527,一种鸟嘌呤核苷酸类似物的双前药,是一种有效的 SARS-CoV-2 抑制剂,也是一种有前途的口服抗 COVID-19 病毒药物。
Antimicrob Agents Chemother. 2021 Mar 18;65(4). doi: 10.1128/AAC.02479-20.

引用本文的文献

1
Antimalarial compounds exhibit variant- and cell-type-specific activity against SARS-CoV-2 isolated in Panama.抗疟化合物对在巴拿马分离出的新型冠状病毒具有变异体和细胞类型特异性活性。
Front Pharmacol. 2025 Jun 4;16:1537053. doi: 10.3389/fphar.2025.1537053. eCollection 2025.
2
Artesunate-Nanoliposome-TPP, a Novel Drug Delivery System That Targets the Mitochondria, Attenuates Cisplatin-Induced Acute Kidney Injury by Suppressing Oxidative Stress and Inflammatory Effects.青蒿琥酯纳米脂质体-TPP,一种新型的靶向线粒体的药物递送系统,通过抑制氧化应激和炎症反应来减轻顺铂诱导的急性肾损伤。
Int J Nanomedicine. 2024 Feb 12;19:1385-1408. doi: 10.2147/IJN.S444076. eCollection 2024.
3
Bridged 1,2,4-Trioxolanes: SnCl-Catalyzed Synthesis and an In Vitro Study against .
桥连 1,2,4-三恶烷:SnCl 催化合成及体外抗. 研究
Molecules. 2023 Jun 22;28(13):4913. doi: 10.3390/molecules28134913.
4
Identification of Small Molecule Inhibitors of Human Cytomegalovirus pUL89 Endonuclease Using Integrated Computational Approaches.采用整合计算方法鉴定人巨细胞病毒 pUL89 内切酶的小分子抑制剂。
Molecules. 2023 May 7;28(9):3938. doi: 10.3390/molecules28093938.
5
The Biological Causes and Consequences of COVID-19: ACE I/D Polymorphism and In-Silico Screening of Potential Bioactive Phytochemicals Against COVID-19.新型冠状病毒肺炎的生物学病因及后果:血管紧张素转换酶I/D多态性与针对新型冠状病毒肺炎的潜在生物活性植物化学物质的计算机模拟筛选
Bioinform Biol Insights. 2022 Dec 15;16:11779322221139061. doi: 10.1177/11779322221139061. eCollection 2022.
6
Germline transformation of L. plant via transformation technology "Floral dip".通过“花浸染”转化技术对植物乳杆菌进行生殖系转化。
Biotechnol Rep (Amst). 2022 Aug 30;36:e00761. doi: 10.1016/j.btre.2022.e00761. eCollection 2022 Dec.
7
Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey.抗新型冠状病毒的抗寄生虫药物:全面文献综述
Microorganisms. 2022 Jun 24;10(7):1284. doi: 10.3390/microorganisms10071284.
8
Lewis Acids and Heteropoly Acids in the Synthesis of Organic Peroxides.有机过氧化物合成中的路易斯酸和杂多酸
Pharmaceuticals (Basel). 2022 Apr 13;15(4):472. doi: 10.3390/ph15040472.
9
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2.新型冠状病毒 PAD 抑制剂对人β冠状病毒 HCoV-OC43 和 SARS-CoV-2 的抗病毒活性。
Antiviral Res. 2022 Apr;200:105278. doi: 10.1016/j.antiviral.2022.105278. Epub 2022 Mar 11.
10
Synthesis and in vitro Study of Artemisinin/Synthetic Peroxide-Based Hybrid Compounds against SARS-CoV-2 and Cancer.青蒿素/合成过氧化物基杂化化合物抗SARS-CoV-2和癌症的合成及体外研究
ChemMedChem. 2022 May 4;17(9):e202200005. doi: 10.1002/cmdc.202200005. Epub 2022 Mar 29.